These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

149 related articles for article (PubMed ID: 36380255)

  • 21. ASO Author Reflections: The Lymph Node Ratio is an Independent Prognostic Factor in Esophageal Squamous Cell Carcinoma After Minimally Invasive Esophagectomy.
    Kitamura Y; Oshikiri T
    Ann Surg Oncol; 2021 Aug; 28(8):4529. PubMed ID: 33399999
    [No Abstract]   [Full Text] [Related]  

  • 22. ASO Author Reflections: Response to Neoadjuvant Chemotherapy Strengthens the Prognostic Impact of Pathological Stage for Esophageal Squamous Cell Carcinoma.
    Matsuda S; Kawakubo H; Okamura A; Takahashi K; Toihata T; Takemura R; Mayanagi S; Takeuchi H; Watanabe M; Kitagawa Y
    Ann Surg Oncol; 2021 Dec; 28(13):8448-8449. PubMed ID: 34143335
    [No Abstract]   [Full Text] [Related]  

  • 23. ASO Author Reflections: Serine Protease 27 is a Novel Prognostic Indicator for Esophageal Squamous Cell Carcinoma with Preoperative Treatment.
    Kataoka A; Yamada K; Kawamura YI
    Ann Surg Oncol; 2021 Sep; 28(9):5382-5383. PubMed ID: 33454876
    [No Abstract]   [Full Text] [Related]  

  • 24. ASO Author Reflections: Biomarkers for Neoadjuvant Chemoradiation Therapy in Esophageal Squamous Cell Carcinoma.
    Okumura H; Noda M; Natsugoe S
    Ann Surg Oncol; 2018 Dec; 25(Suppl 3):715-716. PubMed ID: 30288651
    [No Abstract]   [Full Text] [Related]  

  • 25. ASO Author Reflections: Timing of Surgery and Chemoradiation for Esophageal Squamous Cell Carcinoma.
    Wong LY; Berry MF
    Ann Surg Oncol; 2023 Apr; 30(4):2224-2225. PubMed ID: 36607525
    [No Abstract]   [Full Text] [Related]  

  • 26. ASO Author Reflections: Intramural Metastasis as Dismal Prognostic Factor in Esophageal Squamous Cell Carcinoma.
    Ushimaru Y; Makino T; Doki Y
    Ann Surg Oncol; 2023 Aug; 30(8):5203-5204. PubMed ID: 37285094
    [No Abstract]   [Full Text] [Related]  

  • 27. ASO Author Reflections: Timing of Oesophagectomy After Neoadjuvant Chemoradiotherapy for Locally Advanced Oesophageal Cancer.
    Xiao X; Cheng C; Cheng L; Yuan Y
    Ann Surg Oncol; 2023 Feb; 30(2):897-898. PubMed ID: 36322273
    [No Abstract]   [Full Text] [Related]  

  • 28. ASO Author Reflections: Prediction of the Response to Neoadjuvant Therapy by Patients with Esophageal Squamous Cell Carcinoma.
    Okamura A; Watanabe M; Okui J; Matsuda S; Takemura R; Kawakubo H; Takeuchi H; Muto M; Kakeji Y; Kitagawa Y; Doki Y
    Ann Surg Oncol; 2023 Apr; 30(4):2186-2187. PubMed ID: 36538253
    [No Abstract]   [Full Text] [Related]  

  • 29. ASO Author Reflections: A Novel Station-Based Nodal Staging System for Esophageal Squamous Cell Carcinoma.
    Yuan Y; Hong HG; Chen LQ
    Ann Surg Oncol; 2019 Dec; 26(Suppl 3):782-783. PubMed ID: 31605350
    [No Abstract]   [Full Text] [Related]  

  • 30. ASO Author Reflections: Nodal Skip Metastasis in Esophageal Squamous Cell Carcinoma.
    Kumakura Y; Yokobori T; Sohda M; Shirabe K; Kuwano H
    Ann Surg Oncol; 2018 Dec; 25(Suppl 3):741-742. PubMed ID: 30315381
    [No Abstract]   [Full Text] [Related]  

  • 31. ASO Author Reflections: Implementation of Age and Co-morbidity in the Treatment Guideline of Patients with Esophageal Squamous Cell Carcinoma.
    Faiz Z; Plukker JTM
    Ann Surg Oncol; 2019 Dec; 26(Suppl 3):585-586. PubMed ID: 31011909
    [No Abstract]   [Full Text] [Related]  

  • 32. ASO Author Reflections: Serum Squamous Cell Carcinoma Antigen in Recurrent Esophageal Squamous Cell Carcinoma.
    Kanie Y; Okamura A; Watanabe M
    Ann Surg Oncol; 2021 Nov; 28(12):7997-7998. PubMed ID: 33860360
    [No Abstract]   [Full Text] [Related]  

  • 33. ASO Author Reflections: NADPH Oxidase 2 has Potential as a Therapeutic Target for Esophageal Squamous Cell Carcinoma.
    Shimizu H; Katsurahara K; Inoue H; Shiozaki A; Otsuji E
    Ann Surg Oncol; 2022 Dec; 29(13):8688-8689. PubMed ID: 35986132
    [No Abstract]   [Full Text] [Related]  

  • 34. ASO Author Reflections: Can Circulating Tumor DNA Guide Individualized Treatment for Patients with Esophageal Squamous Cell Carcinoma?
    Morimoto Y; Matsuda S; Kawakubo H; Nakamura K; Kobayashi R; Hisaoka K; Okui J; Takeuchi M; Aimono E; Fukuda K; Nakamura R; Saya H; Nishihara H; Kitagawa Y
    Ann Surg Oncol; 2023 Jun; 30(6):3757-3758. PubMed ID: 36807023
    [No Abstract]   [Full Text] [Related]  

  • 35. ASO Author Reflections: Expression and Malignant Potential of B4GALNT4 in Esophageal Squamous Cell Carcinoma.
    Baba H; Kanda M; Kodera Y; Fujii T
    Ann Surg Oncol; 2020 Sep; 27(9):3257-3258. PubMed ID: 32277319
    [No Abstract]   [Full Text] [Related]  

  • 36. ASO Author Reflections: Optimizing Proximal Esophageal Squamous Cell Carcinoma Treatment.
    Patel DC; Berry MF
    Ann Surg Oncol; 2023 Feb; 30(2):828-829. PubMed ID: 36258059
    [No Abstract]   [Full Text] [Related]  

  • 37. ASO Author Reflections: Expression and Role of CFTR in Human Esophageal Squamous Cell Carcinoma.
    Matsumoto Y; Shiozaki A; Otsuji E
    Ann Surg Oncol; 2021 Oct; 28(11):6437-6438. PubMed ID: 33710507
    [No Abstract]   [Full Text] [Related]  

  • 38. ASO Author Reflections: CD36 Expression Is Associated with Cancer Aggressiveness and Energy Source in Esophageal Squamous Cell Carcinoma.
    Yoshida T; Yokobori T; Kuriyama K; Sakai M; Sano A; Ogawa H; Sohda M; Saeki H; Kuwano H; Shirabe K
    Ann Surg Oncol; 2020 Dec; 27(Suppl 3):791-792. PubMed ID: 32591954
    [No Abstract]   [Full Text] [Related]  

  • 39. ASO Author Reflections: ANO9 Regulated Cell Cycle in Human Esophageal Squamous Cell Carcinoma.
    Katsurahara K; Shiozaki A; Otsuji E
    Ann Surg Oncol; 2020 Sep; 27(9):3231-3232. PubMed ID: 32206949
    [No Abstract]   [Full Text] [Related]  

  • 40. Definitive chemoradiotherapy has comparable survival outcomes to esophagectomy in patients with clinical T1N0M0 esophageal squamous cell carcinoma: real-world data.
    Sawada K; Kotani D; Yukami H; Mishima S; Fujiwara H; Kadota T; Nakajo K; Yoda Y; Nakamura M; Hojo H; Yano T; Fujita T; Kojima T
    Int J Clin Oncol; 2022 Aug; 27(8):1279-1288. PubMed ID: 35779118
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.